(Total Views: 238)
Posted On: 05/18/2021 11:40:50 AM
Post# of 27

$MBIO News Article - Mustang Bio and City of Hope Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13R?2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors https://marketwirenews.com/news-releases/must...41157.html


My Twitter: WhyteStocks